C entral nervous system (CNS) microglia are resident, myeloid lineage-related cells that, in normal conditions, display no phagocytic or endocytic activity and express low levels of MHC class II molecules and activation markers (e.g., CD45, CD14, and Fc receptors) (1) . In response to injury, inflammation, or neuronal degeneration, microglia acquire the phenotype and functional properties of typical tissue macrophages (1, 2) . Because microglia up-regulate the expression of MHC class II molecules in various CNS pathologies (2, 3) , a key function of activated microglia is thought to be the MHC class II-restricted presentation of processed antigenic peptides to CD4 ϩ Th cells. In multiple sclerosis, a demyelinating CNS disease of putative autoimmune etiology, microglia phagocytose myelin and express MHC class II and adhesion/costimulatory molecules (CD40, CD54, CD80/CD86), indicating that presentation of myelin Ags by this cell type may contribute to the stimulation of autoreactive CD4 ϩ Th1 cells (4 -8) . This concept is supported by several studies in which microglia from the rodent and human CNS were shown to function as APC in vitro (8 -14) .
The sequential steps leading to reciprocal microglia-T cell activation as well as the relative importance of contact-mediated vs cytokine-induced effects on microglia APC function are still unclear. IFN-␥, a cytokine secreted by NK and Th1 cells, induces the expression of MHC class II molecules on microglia in vitro and in vivo (9, 15) . IFN-␥ also up-regulates the expression of adhesion/ costimulatory molecules on cultured mouse or human microglia (3, 6, 13, 14) and strongly enhances the microglia ability to restimulate Th1 and Th2 cells (14) or to activate naive T cells (11, 13) , although less efficiently than dendritic cells (DC) 3 (16) . Th1 cells, in turn, stimulate cultured microglia to secrete IL-12 and PGE 2 , an enhancer and inhibitor of Th1 responses, respectively, indicating a role for microglia-Th1 interactions in the amplification and regulation of T cell-mediated neuroinflammatory processes (17) . Because cultured microglia from the neonatal mouse or adult human CNS exhibit a phagocytic, macrophage-like phenotype (1, 9) , the above studies suggest that already activated microglia productively interact with CD4 ϩ T cells but do not allow us to draw conclusions on the outcome of the interactions between resting microglia and preactivated T cells. Recent work by Sedgwick and collaborators (12, 18) has shown that following induction of GVHD in the rat and infiltration of the CNS by sparse T cell blasts, rat microglia proliferate, up-regulate surface molecules (MHC class II, CD45, CD4), and develop into an APC capable of sustaining T cell effector functions (e.g., IFN-␥ and TNF secretion), but not T cell proliferation or IL-2 secretion, in ex vivo functional assays. In the GVHD model, activated, MHC class II ϩ microglia were detected both in close proximity to T cells and throughout the CNS parenchyma. Whether microglia activation and acquisition of APC features are induced directly by T cells or soluble factors from the injured CNS are also involved remains unclear.
In the present study we sought to determine to what extent T cells directly induce microglia to mature into a competent APC. To mimic the encounter between resting microglia and preactivated T cells, we cocultured microglia acutely isolated from the adult BALB/c mouse CNS with Th1 and Th2 cell lines from DO11.10 TCR transgenic mice, which is probably a more adequate model than those previously used to dissect the early steps involved in microglia activation. We also asked whether signals that are known to be released in the injured CNS, such as TNF, M-CSF, and GM-CSF, would prime resting microglia for enhanced APC function. The results demonstrate that direct interaction with Th1, but not Th2, cells and the Th1-derived cytokine IFN-␥ induce typical APC molecules on microglia and their functional maturation into an APC capable of T cell restimulation. Moreover, we show that GM-CSF primes microglia for enhanced Th1 stimulatory capacity, possibly by increasing microglia responsiveness to Th1-derived signals. (20) . Two-to three-month-old female BALB/c mice were used for the preparation of adult microglia.
Materials and Methods

Mice
Isolation of microglia
Microglia were isolated by modification of a previously published, nonenzymatic procedure (21) . Briefly, mice were sacrificed with an overdose of anaesthetic and perfused with ice-cold glucose-containing buffered saline, GKN (8 g/L NaCl, 0.4 g/L KCl, 3.56 g/L Na 2 HPO 4 12H 2 O, 0.78 g/L NaH 2 PO 4 2H 2 O, and 2 g/L D(ϩ)-glucose, pH 7.4) (22) . Pooled CNS tissues were mechanically dissociated with GKN containing 0.02% BSA by passing them through a wire mesh. After centrifugation at 200 ϫ g for 10 min, dissociated CNS tissue was resuspended in 70% isotonic Percoll (Pharmacia Biotech, Uppsala, Sweden) and centrifuged for 20 min at 500 ϫ g on a 30:37:70% Percoll gradient. Microglia were obtained from the 37 (1.048 g/ml):70% (1.086 g/ml) interface, passed through a 30-m pore size filter, washed, and resuspended in RPMI supplemented with 50 M 2-ME, 2 mM L-glutamine, 50 g/ml gentamicin, and 10% FCS. Cells were plated at the desired density in 96-well flat-bottom tissue culture plates. Anti-CD11b (Mac-1)-coated magnetic microbeads (Miltenyi-Biotec, Bergish, Germany) were used for positive selection of microglia.
DC preparation
DC were enriched from inguinal lymph nodes of 2-to 3-mo-old BALB/c mice immunized with CFA into the hind footpads 6 days earlier, as previously described (23) . Briefly, lymph node cells were depleted of T cells by cytotoxic elimination with HO-13-4 anti-Thy 1.2 Ab (TIB 99) followed by rabbit complement. Thy 1.2-negative cells were separated by Percoll gradient in low buoyant and high buoyant density cells. DC were purified from low buoyant density cells using anti-CD11c (N418)-coated microbeads (Miltenyi-Biotec). After two rounds of elution on MiniMACS separation columns, a highly enriched population of DC (85-95% N418 ϩ cells) was obtained. As previously shown (24) , the Ag-presenting capacity of DC was not affected by positive selection with N418 mAb.
T cell lines
CD4
ϩ cells were positively selected from inguinal and mesenteric lymph nodes of naive DO11.10 TCR transgenic mice by anti-CD4-coated magnetic microbeads (Miltenyi-Biotec). CD4 ϩ T cells (2 ϫ 10 5 cells/well) were cultured with OVA peptide 323-339 (0.3 M), and mitomycin Ctreated BALB/c splenocytes (5 ϫ 10 6 cells/well) as APC in a total volume of 2 ml in 24-well plates in the presence of either 0.1 ng/ml recombinant mouse IL-12 (Hoffmann-La Roche, Nutley, NJ) and 10 g/ml anti-mouse IL-4 (11B11, American Type Culture Collection, Manassas, VA), or 20 ng/ml mouse rIL-4 (Hoffmann-La Roche, Basel, Switzerland) and 10 g/ml anti-mouse IL-12 mAb (10F6, Hoffmann-La Roche, Nutley, NJ) to obtain Th1 or Th2 cell lines, respectively. Cells were cultured in RPMI supplemented with 50 M 2-ME, 2 mM L-glutamine, 50 g/ml gentamicin, and 10% FCS (Sigma, St. Louis, MO). After 3 days in vitro, T cells were expanded and grown in complete medium containing 10 ng/ml of recombinant human IL-2 (Hoffmann-La Roche, Basel, Switzerland). The cell lines obtained exhibited a clear Th1 or Th2 profile, as detected by intracellular staining for IFN-␥ and IL-4 production (14) .
T cell stimulation assay
Graded numbers of mouse microglia or DC were seeded in 96-well flatbottom tissue culture plates and tested for the ability to restimulate T cells immediately after seeding. Microglia Ag-presenting function was also tested after 24 -120 h of culturing without or with mouse recombinant IFN-␥ (10 U/ml), TNF (10 ng/ml), M-CSF (20 and 50 ng/ml; all from Genzyme, Cambridge, MA), GM-CSF (100 U/ml; R & D Systems, Abingdon, U.K.), or LPS from Escherichia coli, serotype 026:B6 (100 ng/ml; Sigma). Before addition of T cells, microglia were gently washed three times with complete medium to remove the stimulating agents. OVA TCR transgenic Th1 or Th2 cells were added (5 ϫ 10 4 ) to wells containing microglia or DC in the presence or the absence of optimal concentrations of OVA 323-339 (0.3 M) or native OVA (10 M; grade V, from Sigma) (14) . For inhibition of Ag presentation, anti-MHC class II (I-A b,d ) mAb (B21.22, American Type Culture Collection; 10 g/ml) was added to the cultures 30 min before addition of T cells. In some experiments, neutralizing rat anti-mouse IFN-␥ mAb (XMG1.2) and rat IgG1 isotypic control Ab (10 g/ml; both from PharMingen, San Diego, CA) were added at culture initiation. For analysis of T cell-derived cytokines, supernatants from duplicate or triplicate cultures were harvested after 24 or 48 h, centrifuged at 1200 rpm, and stored at Ϫ20°C until used for cytokine determination.
IL-2, IFN-␥, and IL-4 were quantified by two-site sandwich ELISA (Genzyme). Detection limits for all cytokines were in the range of 5-15 pg/ml.
Immunocytochemical staining and flow cytometric analysis
Immunocytochemical stainings were performed on freshly isolated microglia, microglia cultured in the absence or the presence of stimulating agents, and microglia-T cell cocultures. Cells were washed with FACS buffer (HBSS containing 0.1% sodium azide and 2% FCS) and preincubated with anti-mouse CD16/CD32 mAb (2.4G2, from PharMingen) for 10 min at 4°C to block nonspecific binding to Fc receptors. For single or double stainings, the following fluorochrome-conjugated mAbs (all from PharMingen) were used at optimal dilutions: rat anti-mouse Mac-1/ CD11b-PE or -FITC (M1/70, IgG2b), rat anti-mouse CD45-PE (30-F11, IgG2b), rat anti-mouse CD86-FITC (GL1, IgG2a), hamster anti-mouse CD40-FITC (HM40 -3, IgM), hamster anti-mouse CD54-FITC (3E2, IgG), mouse anti-mouse MHC class II (I-A d )-FITC (39-10-8, IgG3), hamster anti-mouse CD11c-FITC (HL3, IgG), and rat anti-mouse CD4-Cy-Chrome (H129.19, IgG2a). The background fluorescence was evaluated by staining the cells with isotype control Abs: rat IgG2b-PE or-FITC, rat IgG2a-FITC, mouse IgG3-FITC, hamster IgG-and IgM-FITC, and mouse IgG2a-CyChrome (all from PharMingen). At the end of incubations, cells were washed three times with FACS buffer. Two-color analysis was performed on a FACScan using LYSYS II software (Becton Dickinson, Mountain View, CA); 3000 -5000 events were reported.
Results
Phenotype and in vitro behavior of microglia isolated from the adult mouse CNS
Intraparenchymal microglia were enriched by Percoll gradient from the perfused CNS of adult BALB/c mice, immunostained immediately after isolation, and analyzed by flow cytometry. In agreement with previous studies (22, 25) , microglia were identified as a homogeneous population of double-labeled CD11b ϩ /CD45 ϩ cells, comprising 88 -93% of the freshly isolated cells (Fig. 1, A and B). The intensity of CD45 staining on microglia was much lower than that on splenic cells (Fig. 1D) , and this has been reported to distinguish microglia from CNS perivascular and other tissue macrophages (22) . Among cells isolated from the CNS, only a few (Յ5%) expressed high levels of CD45 but no CD11b (Fig.  1B) , and Ͻ2% were CD4 ϩ T cells (not shown). No cells expressed CD11c, a marker for DC in lymphoid organs (not shown).
In an attempt to obtain an almost pure microglial cell population, microglia were positively selected by incubation with antiCD11b-coated magnetic microbeads. A cell population highly enriched (by 96 -98%) in CD11b ϩ /CD45 low microglia was obtained ( Fig. 1C ), but nearly all the positively selected cells died within a few hours after seeding, suggesting that the selection procedure negatively affects microglial survival. Therefore, all subsequent experiments were performed with freshly isolated microglia enriched by Percoll gradient without further purification. After seeding at a relatively high density (3 or 9 ϫ 10 5 cells/well in 96-well plates) in FCS-containing medium, most microglial cells loosely adhered to the plastic without extending cytoplasmic processes. About 50% of microglial cells (range, 42-56 in two different experiments) survived after 24 h in vitro, as assessed by trypan blue exclusion of resuspended cells. After 3 days in vitro, microglia were still loosely adherent to the plastic surfaces and few extended thin processes. At this time no further decrease in the number of living cells was detected, indicating adaptation of microglia to culture conditions.
Interaction of microglia with Th1, but not Th2, cells induces expression of MHC class II and adhesion/costimulatory molecules
Ex vivo analyzed CD11b
ϩ microglia were largely MHC class II Ϫ , CD40
Ϫ , and CD86 Ϫ , and only a small proportion (10 -15%) expressed CD54 (Fig. 2) . To test whether expression of these molecules is up-regulated by interaction with T cells, microglia-enriched populations were cultured either alone or together with polarized Th1 or Th2 cell lines from DO11.10 TCR transgenic BALB/c mice in the absence or the presence of OVA 323-339 . After about 40 h of culture, the cells were double labeled with antiCD11b and anti-MHC class II, -CD40, -CD54, or -CD86 mAbs and analyzed by flow cytometry. In agreement with a previous study (25) , only CD86 was spontaneously up-regulated on most (50 -75%) short term cultured adult microglia, whereas MHC class II, CD40, and CD54 were expressed on a minority of the cells (4 Ϯ 1, 12 Ϯ 3, and 12 Ϯ 4%, respectively; mean Ϯ SEM of three experiments). A representative experiment is shown in Fig. 2 . Following interaction of microglia with Th1 cells in the absence of Ag, the percentages of CD11b ϩ cells coexpressing MHC class II and CD54 molecules rose to 25-35 and 30 -65%, respectively (results from two experiments), indicating a certain stimulating effect of microglia-T cell interactions even in the absence of Th1 activation and cytokine secretion (see below). However, it was only in the presence of OVA 323-339 that the microglia-Th1 interaction induced the highest percentages of CD11b ϩ microglia coexpressing MHC class II (55 Ϯ 13%), CD40 (34 Ϯ 3%), and CD54 (75 Ϯ 14%; mean Ϯ SEM of three experiments; see a representative experiment in Fig. 2 ). During Ag presentation by microglia, upregulation of CD54 and de novo expression of CD40 were also observed on a substantial proportion (ϳ60 and 80%, respectively) of the CD11b Ϫ cells (mostly Th1 cells), suggesting that the CD40-CD154 and CD54-CD11a/CD18 pathways may be involved in T-T cell interactions.
Following a 40-h interaction of microglia with Th2 cells in the absence of OVA 323-339 , the expression of MHC class II, CD40, CD54, and CD86 molecules on CD11b ϩ microglia did not significantly differ from that detected on microglia cultured alone (Fig.  2) . Coculture of microglia with Th2 cells in the presence of OVA 323-339 induced only a very modest up-regulation in the percentage of CD11b ϩ cells coexpressing MHC class II and CD54 (11 Ϯ 0.5 and 22 Ϯ 1%, respectively; mean Ϯ SEM from three experiments), but not CD40 or CD86 molecules.
Collectively, the above data indicate that with the exception of CD86, which is spontaneously expressed in vitro, only interaction with Th1 strongly up-regulates the expression of APC-related surface molecules on microglia.
Freshly isolated microglia induce Th1, but little Th2, activation
We next asked whether adult mouse microglia were able to stimulate cytokine secretion from Th1 and Th2 cells. Coculture of graded numbers of freshly isolated microglia with Th1 cells for 24 -48 h in the presence of OVA 323-339 led to a progressive increase in IFN-␥ and IL-2 secretion (Fig. 3) . While IFN-␥ secretion was readily induced within 24 h, prominent induction of IL-2 was evident only after 48 h. No IL-4 was detectable (not shown). Th1 cytokine secretion was not observed in the absence of Ag and was completely blocked by neutralizing anti-MHC class II mAb (Fig.  3) , indicating that T cell activation was Ag dependent and MHC class II restricted. The finding that in the presence of native OVA (10 M) Th1 activation was lower than that observed in the presence of OVA 323-339 peptide (0.3 M) suggests that ex vivo tested adult microglia do not possess a very efficient Ag uptake and processing machinery (Fig. 3) . This is in contrast with what was reported for phagocytically active microglia obtained from the neonatal mouse brain (14) .
To better define the relative APC potency of adult microglia, we compared them to DC in the presentation of OVA 323-339 to Th1 cells. After 24-h coculture with Th1 cells, it was evident that about 10-fold lower numbers of DC induced IFN-␥ secretion similar to that triggered by adult mouse microglia. However, DC were up to 100-fold more efficient than microglia in inducing IL-2 secretion. At low APC density (Ͻ10 4 /well) only DC were able to induce substantial Th1 activation.
When microglia were cocultured with Th2 cells in the presence of either OVA 323-339 or native OVA, the secretion of IL-4 was induced only with the highest dose (9 ϫ 10 4 /well) of adult mouse microglia. Th2 cells secreted neither IL-2 nor IFN-␥. The modest Th2 activation induced by microglia was Ag and MHC class II dependent. Compared with DC, adult mouse microglia were definitely inefficient Th2 stimulators (Fig. 3) . It is interesting to note that Th2 activation resulted in only a modest up-regulation of MHC class II expression on microglia (Fig. 2) , thus explaining their poor Th2-restimulating capacity.
IFN-␥ is the major Th1-derived cytokine inducing microglia APC function
Subsequent experiments were aimed at identifying the signals involved in stimulation of the APC function of adult mouse microglia. We first examined the role of IFN-␥, a well-known stimulator of APC function in cultured neonatal mouse microglia (3, 9, 13,  14) . To assess the extent of IFN-␥ involvement in the Th1-induced maturation of microglia APC capacity, we added neutralizing antimouse IFN-␥ mAb to microglia-Th1 cocultures and evaluated OVA 323-339 -dependent microglia and T cell activation. Addition of anti-IFN-␥ mAb, but not of an isotypic control, prevented the up-regulation of MHC class II expression on microglia and reduced by about 50% the levels of IL-2 secreted by Th1 cells (Fig.  4 ). These results demonstrate that IFN-␥ is the major Th1-derived factor inducing APC features in microglia.
Adult microglia were also cultured for 24 h with or without IFN-␥ and then tested for the ability to activate Th1 and Th2 cells in the presence of OVA [323] [324] [325] [326] [327] [328] [329] [330] [331] [332] [333] [334] [335] [336] [337] [338] [339] (Fig. 5, left panels) . Compared with freshly isolated microglia, 24-h-cultured, unstimulated microglia were much less efficient APC for Th1 activation (compare Figs. 3 and 5) . The decreased T cell stimulatory capacity of short term cultured microglia could be due to their relatively poor survival in vitro (as mentioned above, ϳ50% of Fig. 6 . Despite a small increase in the mean fluorescent intensity, the constitutive expression of CD86 was not significantly enhanced by IFN-␥.
We next examined the influence on microglia APC function of TNF and LPS, agents able to activate macrophages and induce DC maturation (26) . In agreement with previous data for neonatal mouse microglia (14) , 24-or 48-h pretreatment of microglia with TNF (100 and 500 U/ml) LPS (10 and 100 ng/ml), or IFN-␥ plus LPS did not enhance the capacity of adult mouse microglia to stimulate Th1 and Th2 cytokine secretion above control levels (data not shown). IFN-␥-pretreated microglia and microglia exposed to supernatants (at 1/5 dilution) from cultures of Th1, but not Th2, cells, activated by plate-bound anti-TCR mAb, expressed similar levels of MHC class II and adhesion/costimulatory molecules and induced similar Th1 and Th2 activation (data not shown). This confirms that IFN-␥, rather than other soluble mediators present in Th1 supernatants, is the dominant cytokine inducing microglia APC function.
GM-CSF enhances microglia Th1-restimulating capacity
GM-CSF and M-CSF have been proposed as stimulators of microglia proliferation and activation (1), but contrasting data exist on the capacity of GM-CSF to modulate the APC function of long term cultured rodent microglia (27, 28) . To clarify this issue, we examined the influence of these two mediators on the T cell stimulatory activity of adult mouse microglia. Long (72-120 h), but not short (24 h), pretreatments of microglia with GM-CSF enhanced the capacity of microglia to stimulate cytokine secretion from Th1 cells (Fig. 5) . The slow kinetics of the GM-CSF effect could be due to enhanced microglial responsiveness to GM-CSF with time in vitro, possibly due to increased expression of GM-CSF receptors.
Conversely, no major differences were detected between unstimulated and GM-CSF-pretreated microglia in the stimulation of IL-4 secretion from Th2 cells. The Th1 stimulatory capacity of GM-CSF-pretreated microglia did not differ significantly from that observed after a 24-h pretreatment with IFN-␥ alone. A similar Th1 induction was observed when microglia were pretreated simultaneously with GM-CSF and IFN-␥, suggesting that there was no synergism between the two cytokines (Fig. 5) . Both short and prolonged pretreatments with M-CSF (20 or 50 ng/ml) failed to enhance microglia Ag-presenting capacity (data not shown).
GM-CSF did not induce the proliferation of CD11b ϩ microglia (which in basal conditions fail to divide, as assessed by bromodeoxyuridine incorporation) or cell survival, as assessed by counting trypan blue-excluding cells (data not shown), suggesting that the enhanced APC function was not a direct consequence of increased microglia numbers. As revealed by flow cytometric analysis, GM-CSF failed to increase the expression of MHC class II, CD40, and CD54 molecules on microglia, even following prolonged in vitro treatment (data not shown from two different experiments). These observations suggest that GM-CSF does not directly induce APC features in microglia, but may render microglia more responsive to Th1-derived signals.
Discussion
We have shown that interactions between resting microglia from the adult mouse CNS and Th1 cells induce the expression of MHC class II and adhesion/costimulatory molecules and result in Th1 activation. Conversely, interactions between adult mouse microglia and Th2 cells fail to induce any relevant expression of APCrelated molecules and have little effect on Th2 activation. Substantial Th2 activation is triggered only following microglia exposure to Th1-derived signals, in particular IFN-␥. These results suggest that CNS infiltration by peripherally primed Th1-type cells may induce resident microglia to mature into competent APC able to sustain CD4 ϩ T cell responses within the CNS. Our results indicate that APC-related molecules are induced on microglia even in the absence of detectable MHC class II expression before interaction with Th1 cells. Although maximally stimulated during Ag-specific interactions, the expression of MHC class II and CD54 molecules was already up-regulated in the absence of Ag, suggesting that preactivated T cells express activation-induced surface molecules implicated in MHC class II and CD54 molecule induction. Conversely, CD40 induction required microglia-Th1 interaction via an Ag bridge, which indicates the involvement of additional signals. CD40 is a key molecule for APC activation, since ligation of CD40 by CD154 expressed on T cells up-regulates MHC and costimulatory (CD80/CD86) molecules and induces cytokine secretion in DC and macrophages (29) . We have recently shown that CD40-CD154 interaction and IFN-␥ mediate induction of IL-12 secretion by microglia during MHC class II-restricted, Ag-dependent activation of Th1 cells (17) . The observations that CD86 was undetectable on ex vivo microglia and was spontaneously up-regulated in vitro suggest either that expression of this molecule is kept under tight control by the CNS microenvironment or that culture conditions include CD86-inducing factors.
IFN-␥ secreted during Th1 activation appears to be the most important cytokine inducing microglia APC features. Because activation of differentiated T cells is very rapid and occurs within a few hours (30) , it is likely that Ag bound to yet undetectable MHC class II molecules expressed on ex vivo microglia induces rapid IFN-␥ secretion, which amplifies the bidirectional signaling cascade between microglia and Th1 cells. In vitro exposure of adult FIGURE 5. Ag-presenting function of adult mouse microglia after exposure to IFN-␥ and GM-CSF. In the left panels, microglia were cultured for 24 h in complete medium with or without IFN-␥ (10 U/ml) and/or GM-CSF (100 U/ml). In the right panels, graded numbers of microglia were cultured for 96 -120 h with or without GM-CSF (100 U/ml). IFN-␥ was added to unstimulated or GM-CSF-treated cultures during the last 24 h of incubation. Th1 and Th2 DO11.10 TCR transgenic T cells (5 ϫ 10 4 / well) were then added together with 0.3 M OVA 323-339 . After 24 h, supernatants from duplicate cultures were pooled, and cytokines were measured by two-site ELISA assays. Values are the mean Ϯ SEM from four experiments. Experiments with 96-and 120-h GM-CSF pretreatments (two for each condition) were pooled because they gave similar results. mouse microglia to IFN-␥ also induced MHC class II and adhesion/costimulatory molecules, resulting in enhanced APC potency for both Th1 and Th2 restimulation. This is the first report in which IFN-␥ alone is shown to act on adult mouse microglia ex vivo, with most cells responding to the cytokine. This suggests that functional IFN-␥ receptors are already expressed on resting microglia. In previous reports adult mouse microglia exposed to IFN-␥ plus LPS were shown to exhibit very poor T cell stimulatory function (25) and to preferentially promote a Th1-type phenotype (21) . Because LPS is known to inhibit IFN-␥-induced MHC class II expression in several cell types, including macrophages (Ref. 31 and references therein) and because we have shown that IFN-␥/LPS treatments fail to stimulate the APC function of neonatal (14) and adult (this study) mouse microglia, the use of LPS may be a confounding factor in the analysis of microglia-T cell interactions.
Compared with DC isolated from lymph nodes of CFA-immunized mice, ex vivo tested adult mouse microglia were less efficient APC in inducing IFN-␥ and IL-2 secretion from Th1 cells. This was expected, because mature DC migrating to lymph nodes already display on their surface elevated levels of MHC class II, CD40, CD54, and CD86 molecules. Induction of IL-2 secretion differed profoundly between the two cell types, with microglia stimulating lower levels of IL-2 and with slower kinetics. Because IL-2 secretion by effector T cells was shown to be more dependent than IFN-␥ secretion on CD54 and CD80/CD86 expression by APC (30) , this observation is consistent with their progressive upregulation on adult microglia during contact with Th1 cells. Ford et al. (12) have recently shown that microglia isolated from the CNS of rats undergoing GVHD fail to induce IL-2 secretion from T cell lines in a 24-h assay and induce a certain degree of T cell apoptosis. Discrepancies between this study and the present data could be ascribed to different levels of adhesion/costimulatory molecules expressed on rat and mouse microglia, signals delivered by TCR transgenic vs nontransgenic T cells, as well as the timing of IL-2 detection. Both studies, however, support the concept that adult microglia, compared with professional APC, are poor stimulators of IL-2 secretion by T cells. This has been proposed as a regulatory mechanism to prevent and/or limit T cell reactivity and its deleterious consequences within the CNS parenchyma (12) . It is, however, possible that, at least in certain chronic inflammatory processes, such as multiple sclerosis (2, 5-8), the elevated expression of adhesion/costimulatory molecules (CD40, CD54, CD80) on MHC class II-expressing microglia could promote IL-2 secretion, thus leading to a more sustained T cell response.
We have recently reported that IFN-␥-pretreated neonatal mouse microglia behave as efficiently as DC for Th1 and Th2 restimulation, although they are less potent inducers of naive T cell proliferation and Th1 differentiation (16) . Even following treatment with IFN-␥, adult microglia appear to be less efficient than their neonatal counterparts in T cell restimulation (14, 16) , which could be due to impaired survival in vitro. The Ag-presenting capacity of neonatal microglia could indeed differ due to their activated, phagocytic phenotype and/or the astrocyte-rich milieu in which they are expanded in vitro.
Th2 cells are inefficient in delivering stimulating signals to microglia, consistent with the observation that Th2 cells secrete macrophage/microglia-deactivating factors such as IL-4 and IL-10 (32). Although both preactivated Th1 and Th2 cells express on their surface CD154, which binds to CD40 leading to APC activation (33) , it is clear that Th2 cells lack additional microgliainducing stimuli, such as IFN-␥. The dynamics of Th1 and Th2 responses within the CNS have been examined in various animal models of CNS infection and autoimmunity. Although Th1-type cytokines predominate in the early and acute phases of CNS inflammation, during both the progression and remission phases the presence of Th2-type cytokines was also detected (34 -36) . This suggests that at any time during CNS inflammation both T cell subsets may be activated, and their balance could contribute to the extent and duration of CNS inflammation. Our data indicate that only in a Th1 cytokine-rich environment are microglia induced to display their full stimulatory potential for Th2 activation, thus highlighting the complexity of the intracerebral Th1/Th2 balance.
To date, the nature of the signals triggering microglia activation remains poorly defined, although products released by damaged neurons and/or glial cells are likely to be involved (1) . Compared with resting microglia, microglia activated during CNS injury or infection could respond more promptly to Th1-derived signals and behave as a more potent APC for T cell restimulation. Among the factors synthesized by reactive CNS cells, particularly microglia and astrocytes, M-CSF and GM-CSF have been proposed as major stimulators of microglia proliferation and activation (1) , and increased expression of GM-CSF and M-CSF receptors has been observed in the injured CNS (37) . We have shown that the potency of adult mouse microglia in restimulating Th1 cells was increased after exposure to GM-CSF, but not M-CSF. These data support a previous study showing that GM-CSF increases the capacity of long term cultured neonatal mouse microglia to induce Ag-dependent T cell proliferation (27) , but are at variance with another study showing an inhibitory effect of GM-CSF on microglia APC function (28) . Because GM-CSF fails to stimulate the expression of MHC class II and adhesion/costimulatory molecules in adult mouse microglia, its mode of action does not appear to involve induction of typical APC features. The ability of GM-CSF-primed microglia to sustain Th1, but not Th2, activation suggests that GM-CSF could increase the responsiveness of microglia to Th1-derived signals. Because our initial experiments indicate that, at variance with what was reported for monocytes (38) , GM-CSF does not enhance the expression of IFN-␥ receptors on microglia (F. Aloisi and R. De Simone, unpublished observations), future studies will explore the possibility that GM-CSF affects some steps in the IFN-␥ signal transduction pathway or acts on other microglia-activating pathways.
In conclusion, the present data suggest that Th1 cells recognizing viral or self Ags expressed in the CNS may activate resting as well as GM-CSF-primed microglia, resulting in the generation of an effective APC capable of contributing to the local Th1/Th2 balance. Because mediators released by Th1-activated microglia (e.g., IL-12 and PGE 2 ) as well as costimulatory molecules expressed on their membranes are involved in the regulation of T cell effector function and survival, it is likely that mutual interactions between microglia and Th1 cells might be determinants of the outcome of CNS inflammation.
